Course Description
| Course | Code | Semester | T+P (Hour) | Credit | ECTS |
|---|---|---|---|---|---|
| PHARMACOGNOSY III | PHA4114866 | Fall Semester | 2+0 | 2 | 4 |
| Course Program | Salı 09:00-09:45 Salı 10:00-10:45 |
| Prerequisites Courses | |
| Recommended Elective Courses |
| Language of Course | English |
| Course Level | First Cycle (Bachelor's Degree) |
| Course Type | Required |
| Course Coordinator | Prof.Dr. Fatma TOSUN |
| Name of Lecturer(s) | Assist.Prof. Ayşe Esra KARADAĞ, Prof.Dr. Fatma TOSUN |
| Assistant(s) | |
| Aim | The aim of this course is to provide information about the lipids and essential oils; summarize their chemical properties, biological activities and uses. Lipids, terpenoids and lipid and essential oil containing drugs are the subject of Pharmacognosy III. |
| Course Content | This course contains; Lipids ,Drugs containing lipids,Definition, biosynthetic pathway and properties of terpenoids ,Distribution and structure of monoterpenes and sesquiterpenes,Definition, physical properties, chemical composition and functions of essential oils,Methods of production for essential oils, quality control for drugs containing essential oils and quality control of essential oils.,Pharmacological properties and uses of drugs containing essential oils.,Acyclic monoterpene containing-drugs,Monocyclic monoterpene and bicyclic monoterpene containing drugs,Sesquiterpene containing-drugs,Aromatic compounds containing-essential oil drugs,Resin, oleoresin, oleogumresin and balsam-containing drugs,Diterpenoids, Triterpenoids and Tetraterpenes-Carotenoids,Aromatherapy. |
| Dersin Öğrenme Kazanımları | Teaching Methods | Assessment Methods |
| 1. Will be able to classify chief drugs containing lipids. | 10, 16, 9 | A, D, E |
| 1.1. Define the biosynthetic pathway of terpenoids. | 10, 16, 9 | A, D, E |
| 1.2. Classify terpenic compounds. | 10, 16, 9 | A, D, E |
| 1.3. Explain physical and chemical properties of essential oils. | 10, 16, 9 | A, D, E |
| 1.4. Evaluate the isolation technics of essential oils. | 10, 16, 9 | A, D, E |
| 2. Will be able to summarize biological activity of drugs containing essential oils. | 10, 16, 9 | A, D, E |
| 2.1. Discuss pharmacological effects of essential oils. | 10, 16, 9 | A, D, E |
| 2.2. Define toxicological effects of essential oils. | 10, 16, 9 | A, D, E |
| 2.3. Express uses of essential oils. | 10, 16, 9 | A, D, E |
| 3. Will be able to summarize biological activity of drugs containing resins. | 10, 16, 9 | A, D, E |
| 3.1. Will be able to summarize biological activity of drugs containing balsam. | 10, 16, 9 | A, D, E |
| 3.2. Evaluate the isolation methods of resins, oleoresins and balsams. | 10, 16, 9 | A, D, E |
| 3.3. Will be able to summarize biological activity of carotenoids. | 10, 16, 9 | A, D, E |
| Teaching Methods: | 10: Discussion Method, 16: Question - Answer Technique, 9: Lecture Method |
| Assessment Methods: | A: Traditional Written Exam, D: Oral Exam, E: Homework |
Course Outline
| Order | Subjects | Preliminary Work |
|---|---|---|
| 1 | Lipids | 1.2.3.4 |
| 2 | Drugs containing lipids | 1,2,3,4 |
| 3 | Definition, biosynthetic pathway and properties of terpenoids | 1,2,3,4 |
| 4 | Distribution and structure of monoterpenes and sesquiterpenes | 1,2,3,4 |
| 5 | Definition, physical properties, chemical composition and functions of essential oils | 1,2,3,4 |
| 6 | Methods of production for essential oils, quality control for drugs containing essential oils and quality control of essential oils. | 1,2,3,4 |
| 7 | Pharmacological properties and uses of drugs containing essential oils. | 1,2,3,4 |
| 8 | Acyclic monoterpene containing-drugs | 1,2,3,4 |
| 9 | Monocyclic monoterpene and bicyclic monoterpene containing drugs | 1,2,3,4 |
| 10 | Sesquiterpene containing-drugs | 1,2,3,4 |
| 11 | Aromatic compounds containing-essential oil drugs | 1,2,3,4 |
| 12 | Resin, oleoresin, oleogumresin and balsam-containing drugs | 1,2,3,4 |
| 13 | Diterpenoids, Triterpenoids and Tetraterpenes-Carotenoids | 1,2,3,4 |
| 14 | Aromatherapy | 1,2,3,4 |
| Resources |
| 1-Pharmacognosy III lecture notes will be provided. 2- Fundamentals of Pharmacognosy and Phytotherapy, M. Heinrich, J. Barns, S. Gibbons, E.M. Williamson, Churchill Livingstone, London, 2004. 3- Pharmacognosy, Phytochemistry, Medicinal Plants, J. Bruneton, Lavousier Publishing, London, New York, 1999. 4- Trease and Evans Pharmacognosy, William C. Evans, Elsevier, 16th Edition, 2009. |
Course Contribution to Program Qualifications
| Course Contribution to Program Qualifications | |||||||
| No | Program Qualification | Contribution Level | |||||
| 1 | 2 | 3 | 4 | 5 | |||
| 1 | PQ-1. Skilfully use information technology to access, follow, evaluate and apply current knowledge in the field of Pharmaceutical Sciences. | X | |||||
| 2 | PQ-2. Have advanced knowledge in APIs and DPs. | X | |||||
| 3 | PQ-3. Collaborate with the experts for collection, interpretation, application and declaration of data in Pharmaceutical Sciences field. | X | |||||
| 4 | PQ-4. Provide best patient counseling services and medication therapy management using his/her knowledge and pharmaceutical information systems to improve the quality of life and safety of patient. | ||||||
| 5 | PQ-5. Capable of organizing and administering a drugstore as per responsibilities prescribed under the Pharmacy Law, using skills, knowledge and advanced technology systems. | X | |||||
| 6 | PQ-6. Skilfully use computer programs and advanced technology related to the Pharmaceutical Sciences. | ||||||
| 7 | PQ-7. Provide solutions to the professional issues using scientific knowledge and data. | X | |||||
| 8 | PQ-8. Perform identification, quality control and standardization of the drug products. | X | |||||
| 9 | PQ-9. Prepare and implement developmental plans for his/her subordinates, frequently evaluate their progress and make necessary adjustments. | X | |||||
| 10 | PQ-10. Capable of conducting independent studies with his/her advanced knowledge in pharmaceutical sciences, takes responsibilities in professional organizations and efficiently collaborates with the members of his/her own organization as well as other organizations. | X | |||||
| 11 | PQ-11. Clearly show signs of adoption of life-long learning and openness to further development. | X | |||||
| 12 | PQ-12. Critically evaluate their knowledge in pharmaceutical sciences. | X | |||||
| 13 | PQ-13. Closely follow and evaluate the national and international professional developments. | X | |||||
| 14 | PQ-14. Record and document all professional activities and applications. | X | |||||
| 15 | PQ-15. Communicate all necessary information about medicines to patient, medical personnel and public. | X | |||||
| 16 | PQ-16. Proficient in English to communicate and follow current knowledge in pharmaceutical sciences. | X | |||||
| 17 | PQ-17. Inform officials and organizations about the issues with the quality assurance of pharmaceutical products. | X | |||||
| 18 | PQ-18. Actively involve in the preparation of APIs, every stage of the formulation and production of DPs. | X | |||||
| 19 | PQ-19. Knowledgable in the regulatory rules of new drug application, data protection and patent issues and understand their interrelationship. | ||||||
| 20 | PQ-20. Have awareness of his/her duties, rights and responsibilities and act based on Pharmacy Law and high professional ethical standards. | X | |||||
| 21 | PQ-21. Familiar with and actively pursue the personal and public health, environmental, and work safety issues. | X | |||||
Assessment Methods
| Contribution Level | Absolute Evaluation | |
| Rate of Midterm Exam to Success | 40 | |
| Rate of Final Exam to Success | 60 | |
| Total | 100 | |
| ECTS / Workload Table | ||||||
| Activities | Number of | Duration(Hour) | Total Workload(Hour) | |||
| Course Hours | 14 | 2 | 28 | |||
| Guided Problem Solving | 0 | 0 | 0 | |||
| Resolution of Homework Problems and Submission as a Report | 0 | 0 | 0 | |||
| Term Project | 14 | 2 | 28 | |||
| Presentation of Project / Seminar | 0 | 0 | 0 | |||
| Quiz | 0 | 0 | 0 | |||
| Midterm Exam | 1 | 21 | 21 | |||
| General Exam | 1 | 31 | 31 | |||
| Performance Task, Maintenance Plan | 0 | 0 | 0 | |||
| Total Workload(Hour) | 108 | |||||
| Dersin AKTS Kredisi = Toplam İş Yükü (Saat)/30*=(108/30) | 4 | |||||
| ECTS of the course: 30 hours of work is counted as 1 ECTS credit. | ||||||
Detail Informations of the Course
Course Description
| Course | Code | Semester | T+P (Hour) | Credit | ECTS |
|---|---|---|---|---|---|
| PHARMACOGNOSY III | PHA4114866 | Fall Semester | 2+0 | 2 | 4 |
| Course Program | Salı 09:00-09:45 Salı 10:00-10:45 |
| Prerequisites Courses | |
| Recommended Elective Courses |
| Language of Course | English |
| Course Level | First Cycle (Bachelor's Degree) |
| Course Type | Required |
| Course Coordinator | Prof.Dr. Fatma TOSUN |
| Name of Lecturer(s) | Assist.Prof. Ayşe Esra KARADAĞ, Prof.Dr. Fatma TOSUN |
| Assistant(s) | |
| Aim | The aim of this course is to provide information about the lipids and essential oils; summarize their chemical properties, biological activities and uses. Lipids, terpenoids and lipid and essential oil containing drugs are the subject of Pharmacognosy III. |
| Course Content | This course contains; Lipids ,Drugs containing lipids,Definition, biosynthetic pathway and properties of terpenoids ,Distribution and structure of monoterpenes and sesquiterpenes,Definition, physical properties, chemical composition and functions of essential oils,Methods of production for essential oils, quality control for drugs containing essential oils and quality control of essential oils.,Pharmacological properties and uses of drugs containing essential oils.,Acyclic monoterpene containing-drugs,Monocyclic monoterpene and bicyclic monoterpene containing drugs,Sesquiterpene containing-drugs,Aromatic compounds containing-essential oil drugs,Resin, oleoresin, oleogumresin and balsam-containing drugs,Diterpenoids, Triterpenoids and Tetraterpenes-Carotenoids,Aromatherapy. |
| Dersin Öğrenme Kazanımları | Teaching Methods | Assessment Methods |
| 1. Will be able to classify chief drugs containing lipids. | 10, 16, 9 | A, D, E |
| 1.1. Define the biosynthetic pathway of terpenoids. | 10, 16, 9 | A, D, E |
| 1.2. Classify terpenic compounds. | 10, 16, 9 | A, D, E |
| 1.3. Explain physical and chemical properties of essential oils. | 10, 16, 9 | A, D, E |
| 1.4. Evaluate the isolation technics of essential oils. | 10, 16, 9 | A, D, E |
| 2. Will be able to summarize biological activity of drugs containing essential oils. | 10, 16, 9 | A, D, E |
| 2.1. Discuss pharmacological effects of essential oils. | 10, 16, 9 | A, D, E |
| 2.2. Define toxicological effects of essential oils. | 10, 16, 9 | A, D, E |
| 2.3. Express uses of essential oils. | 10, 16, 9 | A, D, E |
| 3. Will be able to summarize biological activity of drugs containing resins. | 10, 16, 9 | A, D, E |
| 3.1. Will be able to summarize biological activity of drugs containing balsam. | 10, 16, 9 | A, D, E |
| 3.2. Evaluate the isolation methods of resins, oleoresins and balsams. | 10, 16, 9 | A, D, E |
| 3.3. Will be able to summarize biological activity of carotenoids. | 10, 16, 9 | A, D, E |
| Teaching Methods: | 10: Discussion Method, 16: Question - Answer Technique, 9: Lecture Method |
| Assessment Methods: | A: Traditional Written Exam, D: Oral Exam, E: Homework |
Course Outline
| Order | Subjects | Preliminary Work |
|---|---|---|
| 1 | Lipids | 1.2.3.4 |
| 2 | Drugs containing lipids | 1,2,3,4 |
| 3 | Definition, biosynthetic pathway and properties of terpenoids | 1,2,3,4 |
| 4 | Distribution and structure of monoterpenes and sesquiterpenes | 1,2,3,4 |
| 5 | Definition, physical properties, chemical composition and functions of essential oils | 1,2,3,4 |
| 6 | Methods of production for essential oils, quality control for drugs containing essential oils and quality control of essential oils. | 1,2,3,4 |
| 7 | Pharmacological properties and uses of drugs containing essential oils. | 1,2,3,4 |
| 8 | Acyclic monoterpene containing-drugs | 1,2,3,4 |
| 9 | Monocyclic monoterpene and bicyclic monoterpene containing drugs | 1,2,3,4 |
| 10 | Sesquiterpene containing-drugs | 1,2,3,4 |
| 11 | Aromatic compounds containing-essential oil drugs | 1,2,3,4 |
| 12 | Resin, oleoresin, oleogumresin and balsam-containing drugs | 1,2,3,4 |
| 13 | Diterpenoids, Triterpenoids and Tetraterpenes-Carotenoids | 1,2,3,4 |
| 14 | Aromatherapy | 1,2,3,4 |
| Resources |
| 1-Pharmacognosy III lecture notes will be provided. 2- Fundamentals of Pharmacognosy and Phytotherapy, M. Heinrich, J. Barns, S. Gibbons, E.M. Williamson, Churchill Livingstone, London, 2004. 3- Pharmacognosy, Phytochemistry, Medicinal Plants, J. Bruneton, Lavousier Publishing, London, New York, 1999. 4- Trease and Evans Pharmacognosy, William C. Evans, Elsevier, 16th Edition, 2009. |
Course Contribution to Program Qualifications
| Course Contribution to Program Qualifications | |||||||
| No | Program Qualification | Contribution Level | |||||
| 1 | 2 | 3 | 4 | 5 | |||
| 1 | PQ-1. Skilfully use information technology to access, follow, evaluate and apply current knowledge in the field of Pharmaceutical Sciences. | X | |||||
| 2 | PQ-2. Have advanced knowledge in APIs and DPs. | X | |||||
| 3 | PQ-3. Collaborate with the experts for collection, interpretation, application and declaration of data in Pharmaceutical Sciences field. | X | |||||
| 4 | PQ-4. Provide best patient counseling services and medication therapy management using his/her knowledge and pharmaceutical information systems to improve the quality of life and safety of patient. | ||||||
| 5 | PQ-5. Capable of organizing and administering a drugstore as per responsibilities prescribed under the Pharmacy Law, using skills, knowledge and advanced technology systems. | X | |||||
| 6 | PQ-6. Skilfully use computer programs and advanced technology related to the Pharmaceutical Sciences. | ||||||
| 7 | PQ-7. Provide solutions to the professional issues using scientific knowledge and data. | X | |||||
| 8 | PQ-8. Perform identification, quality control and standardization of the drug products. | X | |||||
| 9 | PQ-9. Prepare and implement developmental plans for his/her subordinates, frequently evaluate their progress and make necessary adjustments. | X | |||||
| 10 | PQ-10. Capable of conducting independent studies with his/her advanced knowledge in pharmaceutical sciences, takes responsibilities in professional organizations and efficiently collaborates with the members of his/her own organization as well as other organizations. | X | |||||
| 11 | PQ-11. Clearly show signs of adoption of life-long learning and openness to further development. | X | |||||
| 12 | PQ-12. Critically evaluate their knowledge in pharmaceutical sciences. | X | |||||
| 13 | PQ-13. Closely follow and evaluate the national and international professional developments. | X | |||||
| 14 | PQ-14. Record and document all professional activities and applications. | X | |||||
| 15 | PQ-15. Communicate all necessary information about medicines to patient, medical personnel and public. | X | |||||
| 16 | PQ-16. Proficient in English to communicate and follow current knowledge in pharmaceutical sciences. | X | |||||
| 17 | PQ-17. Inform officials and organizations about the issues with the quality assurance of pharmaceutical products. | X | |||||
| 18 | PQ-18. Actively involve in the preparation of APIs, every stage of the formulation and production of DPs. | X | |||||
| 19 | PQ-19. Knowledgable in the regulatory rules of new drug application, data protection and patent issues and understand their interrelationship. | ||||||
| 20 | PQ-20. Have awareness of his/her duties, rights and responsibilities and act based on Pharmacy Law and high professional ethical standards. | X | |||||
| 21 | PQ-21. Familiar with and actively pursue the personal and public health, environmental, and work safety issues. | X | |||||
Assessment Methods
| Contribution Level | Absolute Evaluation | |
| Rate of Midterm Exam to Success | 40 | |
| Rate of Final Exam to Success | 60 | |
| Total | 100 | |